Follow-up of bladder cancer : The right examinations at the right time

Schedules for the follow-up (FU) of bladder cancer patients are predominantly based on studies with low level of evidence and the resulting guidelines' recommendations that are often founded on expert consensus. FU of non-muscle invasive bladder cancer (NMIBC) includes cystoscopy and cytology a...

Full description

Saved in:
Bibliographic Details
Published in:Urologe. Ausgabe A 2018-06, Vol.57 (6), p.693
Main Authors: Olbert, P, Goebell, P J, Hegele, A
Format: Article
Language:ger
Subjects:
Carcinoma, Transitional Cell - pathology
Carcinoma, Transitional Cell - psychology
Carcinoma, Transitional Cell - therapy
Chemoradiotherapy
Cystectomy
Cystoscopy
Follow-Up Studies
Humans
Neoplasm Invasiveness
Physical Examination
Practice Guidelines as Topic
Quality of Life
Urinary Bladder Neoplasms - pathology
Urinary Bladder Neoplasms - psychology
Urinary Bladder Neoplasms - therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Schedules for the follow-up (FU) of bladder cancer patients are predominantly based on studies with low level of evidence and the resulting guidelines' recommendations that are often founded on expert consensus. FU of non-muscle invasive bladder cancer (NMIBC) includes cystoscopy and cytology as standard, and imaging modalities to a lower extent. FU of muscle-invasive bladder cancer (MIBC) depends primarily on the therapeutic modality chosen and on the stage of disease. In this scenario, FU is complemented by functional and quality of life related aspects. These apply even more for FU in palliative situations. Here, the individual focus is on examinations that might have a consequence in terms of survival and/or symptom relief.
ISSN:1433-0563
DOI:10.1007/s00120-018-0641-3